NOVO NORDISK A/S |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,631 MXN | -1.09% |
|
+2.18% | +49.70% |
| 28/06 | India plans incentives for diabetes, obesity drug makers in 2026, government official says | RE |
| 28/06 | NOVO NORDISK : UBS gives a Neutral rating | ZD |
Quotes 5-day view
End-of-day quote Mexican S.E.| 24/06/2024 | 25/06/2024 | 26/06/2024 | 27/06/2024 | 28/06/2024 | |
|---|---|---|---|---|---|
| Last | 2561 $ | 2667 $ | 2600 $ | 2660 $ | 2631.1 $ |
| Volume | 148 | 169 | 125 | 123 | 293 |
| Change | -0.54% | +4.14% | -2.51% | +2.31% | -1.09% |
| Opening | 2,568.50 | 2,739.79 | 2,653.66 | 2,721.89 | 2,667.01 |
| High | 2,568.50 | 2,739.79 | 2,653.66 | 2,721.89 | 2,667.01 |
| Low | 2,561.00 | 2,667.00 | 2,600.00 | 2,660.00 | 2,630.00 |
Performance
| 1 day | -1.09% | ||
| 1 week | +2.18% | ||
| Current month | +14.67% | ||
| 1 month | +16.68% | ||
| 3 months | +23.82% | ||
| 6 months | +51.21% | ||
| Current year | +49.70% | ||
| 1 year | +97.09% | ||
| 3 years | +223.06% | ||
| 5 years | +439.73% |
Volumes
marketsDaily volume
293
Avg. Volume 20 sessions
1 243
Avg. Volume 20 sessions MXN
3 270 457.30
Avg. Volume 20 sessions USD
178 439.42
Record volume 1
420 498
Record volume 2
407 892
Record volume 3
373 640
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (MXN)
4 458 586 167 685
Capitalization (USD)
640 796 921 192
Net sales (DKK)
232 261 000 000
Net sales (USD)
33 381 015 442
Number of employees
66 015
Sales / Employee (DKK)
3 518 306
Sales / Employee (USD)
505 658
Free-Float
70.22 %
Free-Float capitalization (MXN)
3 149 528 896 024
Free-Float capitalization (USD)
452 656 591 994
Average Daily Capital Traded
0%
Highs and lows
1 week
2 561.00
2 739.79
1 month
2 259.362 764.09
Current year
1 794.282 764.09
1 year
1 303.502 764.09
3 years
838.002 764.09
5 years
449.052 764.09
10 years
311.002 764.09
Indicators
Moving average 5 days
2 623.82
Moving average 20 days
2 571.14
Moving average 50 days
2 341.45
Moving average 100 days
2 199.00
Price spread / (MMA5)
-0.28%
Price spread / (MMA20)
-2.28%
Price spread / (MMA50)
-11.01%
Price spread / (MMA100)
-16.42%
STIM
RSI 9 days
59.83
RSI 14 days
62.30
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.09% | +2.18% | +49.70% | +97.09% | 64TCr | ||
| -0.40% | +2.43% | +55.32% | +97.38% | 82TCr | ||
| +0.25% | -1.74% | -6.75% | -10.31% | 35TCr | ||
| -4.64% | -5.29% | +13.56% | +10.10% | 31TCr | ||
| +1.50% | +0.66% | +10.68% | +29.44% | 30TCr | ||
| +0.23% | -0.93% | +16.57% | +9.99% | 24TCr | ||
| -0.36% | -1.31% | +2.04% | -9.19% | 22TCr | ||
| +0.75% | +2.32% | +13.31% | +8.63% | 22TCr | ||
| -0.40% | +1.39% | +8.48% | +41.18% | 17TCr | ||
| +0.65% | +0.87% | -2.81% | -22.90% | 16TCr | ||
| +0.09% | +2.65% | +0.20% | -9.00% | 12TCr | ||
| -0.32% | -2.91% | -15.31% | -9.94% | 8.55TCr | ||
| +0.05% | -0.95% | -19.06% | -35.20% | 8.42TCr | ||
| +0.23% | -4.35% | +5.47% | +9.06% | 7.88TCr | ||
| +0.33% | +1.36% | +42.67% | +19.52% | 6.56TCr | ||
| -.--% | +1.73% | - | - | 6.37TCr | ||
| Average | -0.28% | -0.27% | +11.60% | +15.06% | ||
| Weighted average by Cap. | -0.41% | +0.04% | +23.45% | +39.45% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +49.70% | ||
| 2023 | +35.46% | ||
| 2022 | +12.34% | ||
| 2021 | +66.43% | ||
| 2020 | +26.08% | ||
| 2019 | +24.43% | ||
| 2018 | -16.49% | ||
| 2017 | +42.93% | ||
| 2016 | -25.10% | ||
| 2015 | +53.27% | ||
| 2014 | +0.80% |
- Stock Market
- Equities
- NOVO B Stock
- NVO N Stock
- Quotes Novo Nordisk A/S
